Clinical Trials in Michigan

Showing 8541-8560 of 12,290 trials

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

NCT01484028

This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.

Johnson & Johnson Vision Care, Inc.275 participantsStarted Nov 2011

Mission Viejo, California, United States • Mission Viejo, California, United States • Pismo Beach, California, United States +12 more locations

COMPLETED41 miles

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

NCT02670577

The scope of this study is to measure the impact of MammaPrint on treatment in Hormone Receptor (HR)-positive HER2-negative breast cancer patients. In addition, the impact of MammaPrint on treatment in patients with T1a/T1b and pN0/pN1 (up to 1 node), Triple Negative or HER2-positive tumors will be assessed.

Breast Cancer

Agendia481 participantsStarted Nov 2015

Palm Springs, California, United States • Miami, Florida, United States • Tampa, Florida, United States +14 more locations

Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Find Trials by Condition in Michigan

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Clinical Evaluation of a Multifocal Contact Lens on Symptomatic Patients

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Comparison of Two Daily Disposable Contact Lenses Over 1-week of Wear

B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency